Joanna Grudzinska

Company: Bayer AG

Job title: Drug Metabolism & Pharmacokinetics Project Manager

Seminars:

Immunogenicity Risk Assessment of mRNA/LNP Therapies 9:30 am

Outlining the importance of the immunogenicity risk assessment for the development of safe mRNA/LNP therapies Summarizing regulatory requirements and providing practical guidance on immunogenicity risk identification and evaluation Emphasizing the impact of immunogenicity risk assessment on the bioanalytical monitoring strategy for all mRNA/LNP components during developmentRead more

day: Day One